cypripedin has been researched along with cgp 71683 a in 2 studies
Studies (cypripedin) | Trials (cypripedin) | Recent Studies (post-2010) (cypripedin) | Studies (cgp 71683 a) | Trials (cgp 71683 a) | Recent Studies (post-2010) (cgp 71683 a) |
---|---|---|---|---|---|
5 | 0 | 4 | 10 | 0 | 6 |
5 | 0 | 4 | 23 | 0 | 4 |
Protein | Taxonomy | cypripedin (IC50) | cgp 71683 a (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.097 | |
Neuropeptide Y receptor type 1 | Homo sapiens (human) | 8.37 | |
Aquaporin-1 | Homo sapiens (human) | 2.7 | |
Neuropeptide Y receptor type 2 | Homo sapiens (human) | 1.89 | |
Neuropeptide Y receptor type 4 | Homo sapiens (human) | 5.74 | |
Neuropeptide Y receptor type 5 | Homo sapiens (human) | 0.0025 | |
Neuropeptide Y receptor type 5 | Rattus norvegicus (Norway rat) | 0.0014 | |
Melanin-concentrating hormone receptor 1 | Homo sapiens (human) | 3.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y | 1 |
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
2 other study(ies) available for cypripedin and cgp 71683 a
Article | Year |
---|---|
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites | 2011 |
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |